What is Imio?
Imio operates at the intersection of biotechnology and large-scale farming, specializing in the development of advanced biological products designed to optimize agricultural efficiency. The company's flagship innovation, Re-Gen, serves as a cornerstone of its value proposition, utilizing a sophisticated microbial process to convert crop residue into highly bioavailable nutrients. By providing a viable, high-performance alternative to traditional chemical fertilizers, Imio addresses the dual challenge of maintaining soil health and maximizing crop yields. The firm's commitment to consistent, climate-resilient performance has established it as a critical partner for modern agricultural enterprises seeking to reduce their environmental impact while simultaneously enhancing profitability through improved resource utilization.
How much funding has Imio raised?
Imio has raised a total of $6M across 1 funding round:
Stock/Share Issuance
$6M
Stock/Share Issuance (2026): $6M, investors not publicly disclosed
Key Investors in Imio
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Imio?
With this major enterprise-level funding, Imio is poised to transition from a high-growth innovator to a dominant market player. The strategic deployment of these funds will likely focus on scaling production capacity for the Re-Gen product line and expanding distribution networks into key international agricultural markets. Furthermore, the company is expected to invest heavily in research and development to broaden its portfolio of microbial-based solutions, ensuring that its offerings remain at the forefront of the green chemistry revolution. As the agricultural industry faces increasing pressure to adopt sustainable practices, Imio's focus on circular nutrient management provides a robust framework for long-term growth and industry-wide adoption.
See full Imio company page
